EP4698149A1 - Zusammensetzung zur behandlung von osteoarthrose - Google Patents

Zusammensetzung zur behandlung von osteoarthrose

Info

Publication number
EP4698149A1
EP4698149A1 EP24724088.0A EP24724088A EP4698149A1 EP 4698149 A1 EP4698149 A1 EP 4698149A1 EP 24724088 A EP24724088 A EP 24724088A EP 4698149 A1 EP4698149 A1 EP 4698149A1
Authority
EP
European Patent Office
Prior art keywords
composition
anyone
composition according
sodium
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24724088.0A
Other languages
English (en)
French (fr)
Inventor
Giulia FONTANAZZA
Caroline Simone MOUSEL
Fabien FUCHEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abiogen Pharma SRL
Original Assignee
Abiogen Pharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma SRL filed Critical Abiogen Pharma SRL
Publication of EP4698149A1 publication Critical patent/EP4698149A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP24724088.0A 2023-04-20 2024-04-18 Zusammensetzung zur behandlung von osteoarthrose Pending EP4698149A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23169052.0A EP4450062A1 (de) 2023-04-20 2023-04-20 Zusammensetzung zur behandlung von osteoarthrose
PCT/EP2024/060568 WO2024218222A1 (en) 2023-04-20 2024-04-18 Composition for the treatment of osteoarthrosis

Publications (1)

Publication Number Publication Date
EP4698149A1 true EP4698149A1 (de) 2026-02-25

Family

ID=86693123

Family Applications (2)

Application Number Title Priority Date Filing Date
EP23169052.0A Withdrawn EP4450062A1 (de) 2023-04-20 2023-04-20 Zusammensetzung zur behandlung von osteoarthrose
EP24724088.0A Pending EP4698149A1 (de) 2023-04-20 2024-04-18 Zusammensetzung zur behandlung von osteoarthrose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP23169052.0A Withdrawn EP4450062A1 (de) 2023-04-20 2023-04-20 Zusammensetzung zur behandlung von osteoarthrose

Country Status (7)

Country Link
EP (2) EP4450062A1 (de)
JP (1) JP2026512761A (de)
KR (1) KR20260015165A (de)
CN (1) CN121398798A (de)
AU (1) AU2024258855A1 (de)
MX (1) MX2025012471A (de)
WO (1) WO2024218222A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052515A1 (it) * 2005-12-29 2007-06-30 Abiogen Pharma Spa Formulazione farmaceutica per il trattamento della osteoartrite
KR20220013588A (ko) * 2011-09-14 2022-02-04 알러간, 인코포레이티드 잔주름 치료를 위한 진피 필러 조성물
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi

Also Published As

Publication number Publication date
CN121398798A (zh) 2026-01-23
KR20260015165A (ko) 2026-02-02
MX2025012471A (es) 2026-01-07
JP2026512761A (ja) 2026-04-20
EP4450062A1 (de) 2024-10-23
WO2024218222A1 (en) 2024-10-24
AU2024258855A1 (en) 2025-11-27

Similar Documents

Publication Publication Date Title
JP6113424B2 (ja) 安定化された多糖の処方のための組成物及び方法
Claes et al. Temporary distraction and compression of a diaphyseal osteotomy accelerates bone healing
JP2020189870A (ja) 関節を治療するための組成物及びキット
AU2018201556B2 (en) Adhesion preventing material
US20140038917A1 (en) Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
KR20140097424A (ko) 유착 방지 또는 지혈에 유용한 의약 조성물
CN1859918B (zh) 透明质酸在制备治疗急性和过劳扭伤、拉伤的药物中的应用
DE10053053A1 (de) Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
JP2019537589A (ja) 安定な水性カプサイシン注射製剤およびその医学的使用
SK12502001A3 (sk) Prostriedok na liečbu artritídy
US20210069235A1 (en) Composition for treating joint disease and kit containing same
CN105473146A (zh) 含有吡罗昔康和透明质酸的用于治疗骨关节炎的液态药物组合物
AU2024258855A1 (en) Composition for the treatment of osteoarthrosis
WO2018038542A1 (ko) 히알루론산과 마그네슘을 포함하는 골관절염 치료를 위한 조성물
RU2712168C1 (ru) Композиция для лечения остеоартрита, содержащая гидрофилизированный сульфасалазин и гиалуроновую кислоту, и способ получения такой композиции
KR102006680B1 (ko) 히알루론산과 마그네슘을 포함하는 골관절염 치료를 위한 안정한 액상 조성물
JP2018536642A (ja) 椎間関節の疾患の処置のための、ヒアルロン酸を含む架橋された血清アルブミン
CN102580104A (zh) 一种用于腔道检查或治疗的麻醉药物组合物及制备方法
RU2413548C1 (ru) Способ лечения остеоартроза коленного сустава
KR20230015781A (ko) 저점도 점안 조성물의 제조방법
WO2001019359A2 (en) Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
US10925839B2 (en) Composition for treating joint disease and kit containing same
RU2827073C1 (ru) Средство для лечения артрологических заболеваний в лиофилизированной форме для инъекций
JPH11279205A (ja) ヒアルロン酸類製剤の分解抑制方法
KR20060049858A (ko) 골절 치료용 약제학적 조성물

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR